-
公开(公告)号:US20240101687A1
公开(公告)日:2024-03-28
申请号:US18480071
申请日:2023-10-03
Applicant: ABL Bio Inc.
Inventor: Jinhyung AHN , Sungwon AN , Dongin KIM , Eunsil SUNG , Jaehyun EOM , Sang Hoon Lee , Weonkyoo YOU , Juhee KIM , Kyungjin PARK , Hyejin CHUNG , Jinwon JUNG , Bora LEE , Byungje SUNG , Yeunju KIM , Yong-Gyu SON , Seawon AHN , Daehae SONG , Jiseon YOO , Youngdon PAK , Donghoon YEOM , Yoseob LEE , Jaeho JUNG
CPC classification number: C07K16/2863 , A61K47/6845 , C07K16/18 , C07K2317/31 , C07K2317/565 , C07K2317/567
Abstract: The present invention relates to a bi-specific antibody that specifically binds to alpha-synuclein and IGF1R, and an use of the bi-specific antibody for the prevention, treatment and/or diagnosis of synucleinopathies associated with alpha-synuclein or alpha-synuclein aggregates, and can allow the alpha-synuclein antibody or an antigen-binding fragment thereof to penetrate the blood brain barrier to exert its action in the brain, and extend the half-life to maintain the efficacy for a long time.
-
公开(公告)号:US20220056136A1
公开(公告)日:2022-02-24
申请号:US17298741
申请日:2019-02-15
Applicant: ABL BIO INC. , I-MAB BIOPHARMA CO., LTD
Inventor: Eunyoung PARK , Yangsoon LEE , Hyejin CHUNG , Eunsil SUNG , Jiseon YOO , Minji PARK , Yong-Gyu SON , Hyoju CHOI , Eunjung KIM , Jaeho JUNG , Weon-Kyoo YOU , Sang Hoon LEE , Lei FANG , Wenqing JIANG
Abstract: The present disclosure provides an anti-PD-L1/anti-4-1BB bispecific antibody capable to effectively block the interactions between PD-L1 and its receptor PD-1 and between 4-1BB and its ligand. The bispecific antibody may have high binding affinity to both of a PD-L1 protein and a 4-1BB protein.
-
公开(公告)号:US20210284749A1
公开(公告)日:2021-09-16
申请号:US17053256
申请日:2019-06-26
Applicant: ABL BIO INC.
Inventor: Kyungjin PARK , Hyejin CHUNG , Kyeongsu PARK , Yangsoon LEE , Mikyung CHANG , Jaehyoung JEON , Youngkwang KIM , Junhyun JEONG , Jiseon YOO , Yeunju KIM , Donghoon YEOM , Eunjung KIM , Bora LEE , Jinwon JUNG
Abstract: Provided are an antibody or antigen-binding fragment thereof that specifically binds to a B-cell maturation antigen (BCMA), a method of preparing the same, and use thereof. Accordingly, these can be utilized in effectively preventing or treating cancers.
-
-